Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Claxton

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 13, 2005
Wound healing and TIME; new concepts and scientific applicationsGregory Schultz, David Mozingo, Marco Romanelli, et al.
Applied Health Economics and Health Policy|March 14, 2022
How Responsive is Mortality to Locally Administered Healthcare Expenditure? Estimates for England for 2014/15Stephen Martin, Karl Claxton, James Lomas, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 25, 2021
Authors' Response to: "Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al." by Sampson, Firth, and TowseMarta O Soares, Mark J Sculpher, Karl Claxton
Journal of Clinical Epidemiology|September 22, 2015
Methods to place a value on additional evidence are illustrated using a case study of corticosteroids after traumatic brain injuryClaire McKenna, Susan Griffin, Hendrik Koffijberg, et al.
BMJ Open|October 16, 2021
Causal impact of social care, public health and healthcare expenditure on mortality in England: cross-sectional evidence for 2013/2014Stephen Martin, Francesco Longo, James Lomas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Characterizing structural uncertainty in decision analytic models: a review and application of methodsLaura Bojke, Karl Claxton, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Coverage with evidence development, only in research, risk sharing, or patient access scheme? A framework for coverage decisionsSimon Walker, Mark Sculpher, Karl Claxton, et al.
BMJ (Clinical Research Ed.)|November 27, 2015
How to estimate the health benefits of additional research and changing clinical practiceKarl Claxton, Susan Griffin, Hendrik Koffijberg, et al.
Journal of Health Economics|December 19, 2009
Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisionsClaire McKenna, Zaid Chalabi, David Epstein, et al.
Applied Health Economics and Health Policy|July 21, 2021
How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13Stephen Martin, James Lomas, Karl Claxton, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 13, 2005
Wound healing and TIME; new concepts and scientific applicationsGregory Schultz, David Mozingo, Marco Romanelli, et al.
Applied Health Economics and Health Policy|March 14, 2022
How Responsive is Mortality to Locally Administered Healthcare Expenditure? Estimates for England for 2014/15Stephen Martin, Karl Claxton, James Lomas, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|February 25, 2021
Authors' Response to: "Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al." by Sampson, Firth, and TowseMarta O Soares, Mark J Sculpher, Karl Claxton
Journal of Clinical Epidemiology|September 22, 2015
Methods to place a value on additional evidence are illustrated using a case study of corticosteroids after traumatic brain injuryClaire McKenna, Susan Griffin, Hendrik Koffijberg, et al.
BMJ Open|October 16, 2021
Causal impact of social care, public health and healthcare expenditure on mortality in England: cross-sectional evidence for 2013/2014Stephen Martin, Francesco Longo, James Lomas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Characterizing structural uncertainty in decision analytic models: a review and application of methodsLaura Bojke, Karl Claxton, Mark Sculpher, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Coverage with evidence development, only in research, risk sharing, or patient access scheme? A framework for coverage decisionsSimon Walker, Mark Sculpher, Karl Claxton, et al.
BMJ (Clinical Research Ed.)|November 27, 2015
How to estimate the health benefits of additional research and changing clinical practiceKarl Claxton, Susan Griffin, Hendrik Koffijberg, et al.
Journal of Health Economics|December 19, 2009
Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisionsClaire McKenna, Zaid Chalabi, David Epstein, et al.
Applied Health Economics and Health Policy|July 21, 2021
How Effective is Marginal Healthcare Expenditure? New Evidence from England for 2003/04 to 2012/13Stephen Martin, James Lomas, Karl Claxton, et al.
Pageof 12